ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,373 | -24.8% | 7,066 | -9.1% | 0.05% | -23.0% |
| Q2 2023 | $102,915 | +58.1% | 7,773 | +62.5% | 0.06% | +69.4% |
| Q1 2023 | $65,083 | -49.7% | 4,782 | -27.8% | 0.04% | -47.1% |
| Q4 2022 | $129,289 | +16.5% | 6,620 | +13.6% | 0.07% | +54.5% |
| Q3 2022 | $111,000 | -6.7% | 5,828 | +0.7% | 0.04% | 0.0% |
| Q2 2022 | $119,000 | -11.2% | 5,790 | +39.1% | 0.04% | -26.7% |
| Q1 2022 | $134,000 | -34.6% | 4,161 | -5.7% | 0.06% | -22.1% |
| Q4 2021 | $205,000 | -1.9% | 4,412 | -42.9% | 0.08% | -16.3% |
| Q3 2021 | $209,000 | 0.0% | 7,731 | -5.0% | 0.09% | +7.0% |
| Q2 2021 | $209,000 | -39.4% | 8,134 | -19.4% | 0.09% | -41.1% |
| Q1 2021 | $345,000 | +3.0% | 10,092 | +1.8% | 0.15% | +5.0% |
| Q4 2020 | $335,000 | – | 9,916 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |